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Abstract
Stress hormones can alter metabolic functions in adipose tissue and
liver, as well as the sensitivity of rat white adipocytes and rat atrial
responses to ß-adrenergic agonists. In this study, we examined the
effects of three daily footshock stress sessions on the plasma corticos-
terone, glucose, glycerol and triacylglycerol levels of fed, conscious
male rats, and on the plasma glucose, glycerol and triacylglycerol
levels of the same rats following iv infusions of ß-adrenergic agonists
(isoproterenol: 0.4 nmol kg-1 min-1, noradrenaline: 5.0 µg kg-1 day-1,
and BRL 37344 ([±]-[4-(2-[(2-[3-chlorophenyl]-2-hydroxyethyl)
amino]propyl)phenoxy]acetic acid), a selective ß3-adrenoceptor ago-
nist: 0.4 nmol kg-1 min-1). Plasma corticosterone levels increased
significantly after each stress session, while triacylglycerol levels
increased after the first session and glucose increased after the second
and third sessions. Glycerol levels were unaltered after stress. These
results suggest that repeated footshock stress may induce a metabolic
shift from triacylglycerol biosynthesis to glucose release by hepatic
tissue, with glycerol serving as one of the substrates in both pathways.
Stressed rats were more sensitive to infusion of noradrenaline plus
prazosin and to infusion of isoproterenol, with elevated plasma glu-
cose, glycerol and triacylglycerol levels. The higher sensitivity of
stressed rats to isoproterenol and noradrenaline was probably related
to the permissive effect of plasma corticosterone. Only BRL 37344
increased plasma glycerol levels in stressed rats, probably because ß3-
adrenoceptors are not involved in hepatic triacylglycerol synthesis,
thus allowing glycerol to accumulate in plasma.
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Introduction
The physiological responses to stressors
include cardiovascular, renal, visceral, cuta-
neous, and metabolic changes (1) in which
catecholamines and peptides co-released
from the sympathoadrenal system act as cru-
cial mediators (1). Although the stress re-
sponse enables the organism under attack to
prepare itself quickly for fighting or escap-
ing, prolonged or repeated stress is associ-
ated with a variety of disorders, including
cardiovascular diseases such as hyperten-
sion, myocardial infarction, and arterioscle-
rosis, as well as metabolic diseases such as
diabetes (2). The mechanisms by which stress
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affects glucose and lipid metabolism con-
tinue to be of great interest, but no consensus
has emerged. It is accepted that the central
nervous system plays an important role in
the regulation of hepatic glucose and lipid
metabolism via the sympathetic nervous sys-
tem and cytokines (2). However, the precise
relationship between stress-induced incre-
ments in metabolic hormones and in the
sensitivity of tissues to catecholamines dur-
ing repeated or prolonged stress has not been
demonstrated in vivo.
Several experimental models have been
used to elucidate stress mechanisms, includ-
ing novelty, water immersion (3), immobili-
zation (4,5), swimming (6), and footshock
(7-9). Using a footshock stress paradigm (7),
we demonstrated that ß-adrenergic receptor
signaling was altered in cardiac and adipose
tissues of stressed rats (6-10). Altered myo-
cardial adrenergic receptor signaling has been
demonstrated in several models of cardiac
disease such as heart failure (11,12) and
ischemic heart disease (12), and these pa-
thologies had been associated with stress
(13). Although ß1-, ß2-, and ß3-adrenocep-
tors use the same intracellular signaling path-
way, it is now accepted that signaling through
one or another subtype is fundamentally dif-
ferent (12) and may involve unknown intra-
cellular pathways.
Since these results were obtained for iso-
lated tissues, the question of the physiologi-
cal relevance of these stress-induced alter-
ations in the organism in general remains to
be answered. The effect of stress on glucose
metabolism following electrical stimulation
of the sympathetic nerves and the infusion of
catecholamines, glucagon, or corticosterone
in dogs has been examined (14). Yamada et
al. (5) reported that in fed rats, glucagon and
corticosterone as well as epinephrine act as
synergistic factors to cause stress-induced
hyperglycemia. Moreover, in stress situa-
tions, lipolysis was greatly stimulated, with
an accompanying increase in reesterification
to remove the excess free fatty acids released
(15,16).
In the present study, we examined the
effect of stress on the functional responses
of conscious rats to ß-adrenoceptor agonist
infusion. The plasma levels of corticoster-
one before and after three sessions of foot-
shock stress were used as indicators of stress
intensity, whereas the plasma levels of glu-
cose, triacylglycerol and glycerol were used
as indicators of stress-induced substrate
mobilization. Following the initial measure-
ments, rats received an iv infusion of nor-
adrenaline, isoproterenol or BRL 37344 ([±]-
[4-(2-[(2-[3-chlorophenyl]-2-hydroxyethyl)
amino]propyl)phenoxy]acetic acid), a selec-
tive ß3-adrenoceptor agonist, and the above
parameters were again determined to evalu-
ate whether the response was altered after
stress.
Material and Methods
Animals
Male Wistar rats (Rattus norvegicus)
weighing 250 to 350 g at the beginning of the
experiments were used. The animals were
housed in individual cages (30 x 18 x 20 cm)
in a temperature-controlled room (22oC), on
a 12-h light/dark cycle with lights on at 6:30
am. Standard laboratory chow and tap water
were available ad libitum. During the experi-
ments, the animals were cared for in accor-
dance with the principles for the use of ani-
mals in research and education, as specified
in the Statement of Principles adopted by the
Federation of the American Societies for
Experimental Biology Board. The experi-
mental protocols were also approved by the
Institutional Committee for Ethics in Ani-
mal Experimentation.
Blood vessel catheterization
The rats were anesthetized with xylazine
(50 mg/kg) and ketamine (0.01 mg/kg), and
the left carotid artery was cannulated with
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PE20 tubing connected to PE50 tubing that
was exteriorized in the dorsal interscapular
region where it was fixed to the animals’
skin (17). This method permitted the collec-
tion of blood samples from unanesthetized,
undisturbed freely moving rats. The cath-
eters were siliconized and filled with sodium
citrate (5 mM) prior to insertion. In rats
which received a drug infusion, the left jugu-
lar vein was also cannulated.
Control procedure
On the first day of the experiment, each
rat was placed in the footshock cage where it
remained for 30 min before being returned to
the animal care facilities. During this period,
the power for the footshock cage was turned
off (day 0). On the following three days, this
procedure was repeated with each rat in the
control group, whereas the rats in the stress
group received shocks as described below.
Some rats were cannulated to be used as
blood donors.
Stress procedure
Each rat underwent three daily sessions
of unsignaled, inescapable footshocks. The
animals were placed in a Plexiglas chamber
(26 x 21 x 26 cm) provided with a grid floor
made of stainless-steel rods (0.3 cm in diam-
eter and spaced 1.0 cm apart). During the 30-
min sessions, which occurred between 7:30
and 11:00 am, the footshocks were delivered
by a constant current source controlled by a
microprocessor-based instrument con-
structed at the University’s Biomedical En-
gineering Center. Current intensity was 1.0
mA and duration was 1.0 s at random inter-
vals of 5-25 s (mean interval of 15 s). The
rats were returned to their cages at the end of
each footshock session (10-13).
Experiment 1
The rats remained in the animal care
facilities for at least one week before enter-
ing the experimental protocol. During this
period, the rats were handled for 15 min on
five successive days. The left carotid artery
was then cannulated and the animals were
allowed to recover from surgery for 48 h
before being used. On each of four consecu-
tive days, the rats were brought to a silent
room where they remained for 60 min. A 25-
cm long piece of PE50 polyethylene tubing
filled with 0.9% NaCl was then connected to
the external tip of the cannula. Blood samples
(500 µl) were withdrawn, and the volume
was replaced with blood from a donor rat.
Immediately after each blood sampling, the
cannulas were filled with 5 mM sodium
citrate solution and closed. Blood samples
were collected each day immediately before
and after the rats had been placed in the
experimental cage. The rats were returned to
the animal care facilities immediately after
collection of the second blood sample.
Experiment 2
In this group cannulation was performed
after the second footshock session. On the
next day, immediately after the third foot-
shock or control session, a blood sample
(500 µl) was withdrawn (-15 min) from the
cannulated artery as described above, and
the volume replaced with blood collected
from a naive donor animal. Another sample
was obtained after 15 min (0 min), when
drug infusion was started. Blood samples
were also obtained at 5, 15, 30, 45 and 60
min after starting the infusion which lasted
for 30 min.
Using the cannula implanted into the left
jugular vein, the rats received one of the
following ß-adrenergic agonists: isoprote-
renol (0.4 nmol kg-1 min-1), noradrenaline
(5.0 µg kg-1 min-1), or BRL 37344 (0.4 nmol
kg-1 min-1). Noradrenaline was also infused
with prazosin. In this case, immediately after
the third session the rats received an intra-
peritoneal (ip) injection of prazosin (0.2 mg/
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kg). The infusion of noradrenaline (5.0 µg
kg-1 min-1) plus prazosin (8.3 µg kg-1 min-1)
was then started 30 min later. The dose
regime was based on Galitzky et al. (18).
Analytical determinations
All blood samples were collected into
plastic vials in an ice-water bath and imme-
diately centrifuged at 5000 rpm for 10 min at
4oC. Aliquots of plasma were removed and
stored at -20oC until assayed for plasma
corticosterone, glucose, glycerol and triacyl-
glycerol levels. Plasma glucose was meas-
ured by the glucose oxidase method (com-
mercial kit, Laborlab S/A, São Paulo, SP,
Brazil). Plasma corticosterone was deter-
mined by radioimmunoassay (commercial
kit, ICN Pharmaceuticals, Inc., Costa Mesa,
CA, USA). For glycerol measurements,
plasma was deproteinized prior to the enzy-
matic assay (19). Plasma triacylglycerol lev-
els were also measured by an enzymatic
method (commercial kit, Laborlab).
Drugs and chemicals
ATP, bovine serum albumin (fraction V),
glycerol phosphate dehydrogenase type I
from rabbit muscle, glycerol kinase from
Candida mycoderma, (-)-isoproterenol,
(-)-noradrenaline, prazosin HCl and sodium
citrate were from Sigma (St. Louis, MO,
USA); BRL 37344 was from Tockris
Cookson (Ballwin, MO, USA), xylazine from
Bayer S.A. (São Paulo, SP, Brazil), and
ketamine from Konig S.A. (São Paulo, SP,
Brazil).
Statistical analysis
The results are reported as means ± SEM.
Differences between the plasma levels of
each compound before and after the control
or stress procedure during the four succes-
sive days of experiment 1, and between the
plasma levels at each time interval during or
after drug infusion (experiment 2) were ana-
lyzed by two-way ANOVA for repeated
measures, followed by the Tukey test. Dif-
ferences were considered significant for
P<0.05.
Results
Effect of footshock stress on plasma
corticosterone, glucose, glycerol and
triacylglycerol levels
Figure 1 shows the plasma corticoster-
one levels in fed conscious rats before and
after the control procedure or footshock
stress. There were no differences in the
plasma corticosterone levels among any of
the control groups. In stressed rats, there was
a trend towards an increase in the levels of
corticosterone after stress on days 1, 2 and 3.
However, ANOVA for repeated measures
followed by the Tukey test showed that only
on days 2 and 3 were the plasma corticoster-
one levels after footshock stress significant-
ly higher than those before footshock. Plasma
Figure 1. Plasma corticosterone
levels of fed conscious rats be-
fore and after the control proce-
dure (top) or 30 min of footshock
stress (bottom). On day 0, ani-
mals of both groups were placed
in the footshock cage but did not
receive footshocks (control pro-
cedure). On days 1, 2 and 3, rats
in the stressed group received
120 footshocks (1.0 mA, 1.0 s,
intervals of 5-25 s between
shocks) over a 30-min period.
Rats from the control group re-
mained in the footshock cage
but did not receive footshocks.
The columns represent the
means ± SEM for 5 experi-
ments. *P<0.05 compared to
the control group before and af-
ter the session on days 0, 1, 2
and 3, and P<0.05 compared to
the footshock group before the
session on days 0, 1, and 2.
+P<0.05 compared to the foot-
shock group before the session
on day 2 (ANOVA plus Tukey
test).
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corticosterone levels on day 3 were also
higher than the levels on days 0 and 1
(P<0.05).
Figure 2 shows that the plasma glucose,
glycerol and triacylglycerol levels in the con-
trol group were not significantly different
before or after the control procedure during
the four days of the experiment. In the
footshock group, the plasma glucose levels
on days 2 and 3 increased after footshock
compared to the values before footshock
(P<0.05). Furthermore, on day 3, the plasma
glucose levels were higher than all values in
the control group and in the footshock stress
group, except on day 2 after footshock
(P<0.05). Plasma glycerol levels were not
significantly different before or after the foot-
shock stress on any of the three days. Plasma
triacylglycerol levels increased after foot-
shock stress only on day 1 (P<0.05; Figure
2).
Effect of isoproterenol, noradrenaline,
noradrenaline plus prazosin, or BRL 37344
infusion on plasma glucose, glycerol and
triacylglycerol levels
After the third footshock session, the rats
were kept in their home cages until the plasma
glucose levels decreased to values which
Figure 2. Plasma glucose, glyc-
erol and triacylglycerol levels of
fed conscious rats before and
after the control procedure (left
panels) or 30 min of footshock
stress (right panels). On day 0,
animals of both groups were
placed in the footshock cage but
did not receive footshocks (con-
trol procedure). On days 1, 2
and 3, rats in the stressed group
received 120 footshocks (1.0
mA, 1.0 s, intervals of 5-25 s
between shocks) over a 30-min
period. Rats from the control
group remained in the foot-
shock cage but did not receive
footshocks. The columns repre-
sent the means ± SEM of 5 ani-
mals in each group. +P<0.05
compared to the control group
before and after the session,
and to the footshock group be-
fore session (ANOVA plus
Tukey test). *P<0.05 compared
to the control group after the
session and to the footshock
group before the session
(ANOVA plus Tukey test).
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were not significantly different from basal
values (15 min). At this point, an iv infusion
of saline solution (0.9% NaCl, w/v), isopro-
terenol (0.4 nmol kg-1 min-1), noradrenaline
(5.0 µg kg-1 min-1), or BRL 37344 (0.4 nmol
kg-1 min-1) was started.
The infusion of saline solution in control
rats did not significantly alter the plasma
glucose, glycerol or triacylglycerol levels
(Figure 3). Immediately after the third ses-
sion, plasma glucose levels were higher in
stressed rats than in control rats. During the
subsequent 15 min, the plasma glucose lev-
els of stressed rats decreased to the levels
seen in the control rats. In the control group,
isoproterenol (0.4 nmol kg-1 min-1) increased
the plasma glucose levels after 5 min fol-
lowed by a return to basal values during
infusion (P<0.05; Figure 3). In footshock-
stressed rats, plasma glucose levels were
higher than in the controls during infusion
and 15 min, but not 30 min, after the end of
infusion (P<0.05). Isoproterenol had no ef-
fect on the plasma glycerol levels of control
or footshocked rats (Figure 3). In control
rats, isoproterenol increased the plasma tri-
acylglycerol levels only 60 min after the start
of the infusion (30 min after the end), whereas
in footshock-stressed rats the increase in
plasma triacylglycerol levels was significant
at 30, 45 and 60 min after the onset of the
infusion compared to the values obtained
immediately before infusion (P<0.05; Fig-
ure 3).
Noradrenaline (5.0 µg kg-1 min-1) had no
significant effect on plasma glucose or glyc-
erol levels in either group (Figure 4). Nor-
adrenaline produced a similar profile of varia-
tion in the plasma triacylglycerol levels of
control and footshock-stressed rats (Figure
4), with the levels of triacylglycerol being
significantly lower in stressed rats than in
control rats 15 min after the start of the
infusion and 30 min after the end of infusion
(Figure 4). Since noradrenaline has a potent
vasoconstrictor effect that might affect the
release and/or clearance of substrates in sev-
eral tissues, we examined the effects of nor-
adrenaline in rats which received prazosin
before and during noradrenaline infusion.
An ip injection of prazosin did not affect
the plasma glucose, glycerol or triacylglyc-
erol levels in control rats (Figure 5). How-
ever, in stressed rats which received prazo-
sin, the plasma glucose levels remained high
during the 30 min following ip injection of
prazosin, so that when the infusion started
the levels were higher in stressed rats than in
control rats (Figure 5).
When the infusion of noradrenaline plus
prazosin started, there was no significant
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Figure 3. Effect of iv infusion of
saline solution (0.9% NaCl, w/v)
or isoproterenol (0.4 nmol kg-1
min-1) on plasma glucose, glyc-
erol and triacylglycerol levels in
fed conscious rats after three
daily sessions of confinement in
footshock cages with no foot-
shocks (control) or with foot-
shock stress for 30 min. The in-
fusion (time 0) began 15 min af-
ter the end of the third session.
The points represent the means
± SEM of the number of rats
indicated in parentheses. *P<0.05
compared to the control group;
+P<0.05 compared to the value
at 0 min; **P<0.05 compared to
the values at 5, 15 and 30 min;
#P<0.05 compared to the values
at -15, 0, 5, 15, and 30 min in the
control group (ANOVA plus
Tukey test).
* *
*
*
+
Infusion
+
#
+
**
Infusion
Infusion
+
1203
Braz J Med Biol Res 34(9) 2001
Metabolic markers after stress
increase in plasma glucose levels in control
or stressed rats. At the end of infusion, glu-
cose levels tended to decrease towards pre-
infusion levels, although the values in the
stressed rats were higher than in control rats,
even 30 min after the end of infusion (Figure
5). Similar trends were observed for plasma
glycerol levels. However, there was a peak
in the plasma glycerol levels of stressed rats
15 min after the end of infusion, when triac-
ylglycerol levels were higher in stressed rats
than in control rats (Figure 5).
BRL 37344 (0.4 nmol kg-1 min-1) had no
significant effect on plasma glucose or triac-
ylglycerol levels in either group of rats (Fig-
ure 6). BRL 37344 infusion also had no
significant effect on plasma glycerol levels
in control rats (Figure 6) but increased these
levels in footshock-stressed rats towards the
end of infusion (30 min) followed by a return
to basal levels after the infusion had ended
(Figure 6).
Discussion
An increase in plasma corticosterone in
response to stress is directly related to the
stressor intensity, so that corticosterone is a
useful indicator (3,20). Plasma catechol-
amines also increase during the stress reac-
tion (3,21).
Figure 1 shows that 48 h after surgery,
the plasma corticosterone level of rats was
26.1 ± 2.7 µg/dl. This value was significant-
ly higher than the previously reported level
of 13.0 ± 0.3 µg/dl for male rats sedated with
sodium pentobarbital (8) but was similar to
that measured by De Boer et al. (3,20) in fed
rats transferred to a novel cage and environ-
ment, as done here. Thus, high plasma corti-
costerone levels appear to be typical of con-
scious rats brought to a different environ-
ment and sampled for blood collection while
freely moving in the cage. Confinement in a
footshock cage for 30 min without receiving
any footshock did not alter the plasma corti-
costerone levels, indicating that remaining
in a novel room for 30 min was not an
additional stressor stimulus. However, when
rats received footshocks, plasma corticoster-
one levels increased, as expected, and rep-
etition of the stressor stimulus caused a more
pronounced response, indicating that ani-
mals had not adapted to the stressor. Many
authors have shown that plasma corticoster-
one responses are reduced in rats following
repeated presentation of noise (21,22), han-
dling (23), novelty (24,25) or restraint (26),
whereas with the use of relative intense stres-
sors such as footshock (27), cold exposure
(27), forced running (27,28) or a combina-
Figure 4. Effect of iv infusion of
noradrenaline (5.0 µg kg-1 min-1)
on plasma glucose, glycerol and
triacylglycerol levels in fed con-
scious rats after three daily ses-
sions of confinement in foot-
shock cages with no footshocks
(control) or with footshock
stress for 30 min. The infusion
(time 0) began 15 min after the
end of the third session. The
points represent the means ±
SEM of the number of rats indi-
cated in parentheses. +P<0.05
compared to the value at 45 min;
*P<0.05 compared to the val-
ues at 0 and 30 min for the foot-
shock group (ANOVA plus Tukey
test).
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tion of restraint, light, noise and tailcutting
(29), no such adaptation was detected. Our
stressed rat model presented higher plasma
corticosterone levels before the second and
third footshock sessions compared to con-
trol rats, indicating that with repetition of the
stressful stimulus some anticipation rather
than adaptation to the stressor may occur.
Plasma glucose levels followed a pattern
similar to that of plasma corticosterone lev-
els. In footshock-stressed rats, the glucose
levels increased significantly after the sec-
ond and third stress sessions (Figure 2). This
probably reflects the permissive effect of
corticosterone on the action of catechol-
amines plus the effect of glucagon in stimu-
lating gluconeogenesis and glycogenolysis
in hepatic cells (2,30) and the a-adrenergic
effects of endogenous catecholamines in in-
hibiting insulin secretion (31). In contrast to
plasma glucose, which increased progres-
sively with the repetition of stress, plasma
triacylglycerol levels were not enhanced on
day 2 or 3 but were significantly higher than
control after the first footshock session (Fig-
ure 2). Although we did not measure any
hepatic function indicators, this result sug-
gests that, as the stress is repeated, glucose is
released by the liver instead of triacylglyc-
erol. The use of glycerol released by adipose
tissue as a gluconeogenic substrate may help
to maintain the plasma glycerol level un-
changed after stress despite the adrenergic
stimulation of lipolysis in white adipose tis-
sue (32). Taken together, these findings indi-
cate that repeated stress leads to a wide-
spread or general metabolic response aimed
at maintaining high plasma glucose levels.
This post-stress hyperglycemia is enhanced
by repetition of the stressful stimulus, sug-
gesting a sensitization of this response.
Because we have previously shown that
after this same stress protocol cardiac tissue
and adipocytes are supersensitive to isopro-
terenol and subsensitive to noradrenaline
(7,8) and to BRL 37344 (8), we examined
the effect of an infusion of these compounds
on plasma glucose, glycerol and triacylglyc-
erol levels in stressed rats.
In control rats, the infusion of isoprote-
renol increased glycemia, which peaked by
the fifth minute, followed by a slow decrease
towards the basal value during infusion. This
time course is probably a consequence of the
effect of isoproterenol on hepatic glyco-
genolysis and gluconeogenesis followed by
insulin secretion (33). In footshock-stressed
rats, the glycemia during isoproterenol infu-
sion was higher than in control rats, indicat-
ing that glycogenolysis and gluconeogenesis
were also higher in these animals. Since De
Boer et al. (3,20) have shown that in control
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Figure 5. Effect of iv infusion of
noradrenaline (5.0 µg kg-1 min-1)
plus prazosin (8.3 µg kg-1 min-1)
on plasma glucose, glycerol and
triacylglycerol levels in fed con-
scious rats after three daily ses-
sions of confinement in foot-
shock cages with no footshocks
(control) or with footshock stress
for 30 min. The rats received 0.2
mg of prazosin/kg, ip, immedi-
ately after the third session. The
infusion of noradrenaline began
30 min after the end of the third
session. The points represent
the means ± SEM of the num-
ber of rats indicated in parenthe-
ses. *P<0.05 compared to the
value for the control group;
**P<0.05 compared to the val-
ues at -15 and 0 min for the con-
trol group; +P<0.05 compared to
the value at 0 min; #P<0.05 com-
pared to the values at all other
time points, except for 45 min in
the control group (ANOVA plus
Tukey test).
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rats brought to a novel room the plasma
noradrenaline and adrenaline levels had al-
ready returned to basal values by the end of
a 30-min period, this effect observed in
stressed rats seems to be a consequence of
the high levels of endogenous catecholamine
(34) or of stress-induced insulin resistance
(35). Since isoproterenol stimulated lipoly-
sis (36) as well as insulin release, plasma
glycerol could be used by the liver for triac-
ylglycerol synthesis, thereby maintaining the
plasma glycerol levels unchanged, despite
an increase in lipolysis. Furthermore, the
late permissive effects of corticosterone on
the action of endogenous catecholamine may
have enhanced this metabolic pathway, since
in stressed rats the increase in plasma triac-
ylglycerol levels was faster and higher than
in control rats.
Although noradrenaline has glycogeno-
lytic and gluconeogenic effects in isolated
hepatocytes and lipolytic effects in isolated
adipocytes, when infused in rats its vasocon-
strictor effect in vivo may mask its metabolic
action (37). This may explain why there
were no significant changes in plasma glu-
cose or glycerol levels in the control and
stressed rats infused with noradrenaline. In
control rats, the plasma glucose levels were
not modified by the a1-adrenoceptor antago-
nist, prazosin, but increased during the ini-
tial 5 min of noradrenaline plus prazosin
infusion, slowly decreasing towards basal
levels during and after infusion. However,
when rats received prazosin (Figure 5) im-
mediately after the third footshock session,
the glycemia remained high before and
throughout the period of noradrenaline plus
prazosin infusion and up to 30 min after the
end of the infusion. Thus, the ß-adrenoceptor-
mediated effect of noradrenaline observed
in the presence of prazosin was similar to the
effect of isoproterenol (Figure 3), a selective
ß-adrenoceptor agonist, and was more pro-
nounced in stressed than in control rats.
The time course of changes in plasma
triacylglycerol levels induced by the infu-
sion of noradrenaline was similar in control
and stressed rats. The effect of noradrena-
line in the presence of prazosin differed
between stressed and control rats, with the
former being more sensitive to this catechol-
amine than to isoproterenol.
Tissues from stressed rats are supersensi-
tive to adrenaline (2,7), which is elevated in
stressed rats, and to isoproterenol (7). How-
ever, subsensitivity to noradrenaline has been
reported in cardiac tissue and adipocytes
from stressed rats (7,8). In vivo conditions
are much more complex and involve several
factors which are difficult to control. Even if
isolated tissues were subsensitive to nor-
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Figure 6. Effect of iv infusion of
BRL 37344 (0.4 nmol kg-1 min-1)
on plasma glucose, glycerol and
triacylglycerol levels in fed con-
scious rats after three daily ses-
sions of confinement in foot-
shock cages with no footshocks
(control) or with footshock
stress for 30 min. BRL 37344
infusion began 30 min after the
end of the third session. The
points represent the means ±
SEM of the number of rats indi-
cated in parentheses. +P<0.05
compared to the value at 0 min;
*P<0.05 compared to the val-
ues at 0, 5 and 15 min in the
control group (ANOVA plus
Tukey test).
*
+
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adrenaline, this stress-induced subsensitiv-
ity seems not to be sufficient to overcome the
combined effect of the high levels of endog-
enous catecholamines plus the infused exog-
enous noradrenaline.
BRL 37344 is a selective ß3-adrenoceptor
agonist (38,39) which stimulates lipolysis in
rat white adipocytes (39) and insulin secre-
tion by pancreatic islets (38), but has no
effect on hepatic triacylglycerol synthesis
(40). The infusion of BRL 37344 did not
alter the plasma glucose levels of control or
stressed rats. However, this compound in-
duced a more pronounced increase of plasma
glycerol levels in stressed than in control
rats. Again, the adipocyte subsensitivity to
BRL 37344 demonstrated in vitro seems to
be overcome by the high plasma corticoster-
one and catecholamine levels of stressed
rats.
Our results suggest that stress caused by
repeated footshock may induce metabolic
changes leading to glucose production in-
stead of triacylglycerol biosynthesis. This
pathway probably involves the use of glyc-
erol as a substrate. The in vivo responses to
the infusion of isoproterenol, noradrenaline
and BRL 37344 were more pronounced in
stressed rats than in control rats.
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